107.78
  Price0.67%   +0.71
 
Sep-27-21 07:30AM AbbVie: When The Going Gets ToughSeeking Alpha
06:45AM Could AbbVie's New Collaboration Be a Blockbuster?The Motley Fool
06:06AM 3 High-Yield Dividend Stocks Warren Buffett LovesThe Motley Fool
06:00AM 3 Top Biotech Stocks to Buy for the Long HaulThe Motley Fool
Sep-25-21 12:58PM Barron's Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And MoreBenzinga
10:03AM Opinion: Put a ‘collar’ on your stocks to protect yourself from a market correctionMarketWatch
Sep-25-21 07:05AM Dividend Aristocrats: 5 Buys And 5 SellsSeeking Alpha
06:55AM Why AbbVie Just Made a $1.8 Billion Gene Therapy DealThe Motley Fool
Sep-24-21 09:55AM Opinion: Put a ‘collar’ on your stocks to protect yourself from a market correctionMarketWatch
08:27AM Pharma Stock Roundup: PFE Booster Jab Gets FDA Nod, JNJ's New Data on COVID-19 ShotZacks Investment Research
Sep-23-21 06:03AM 3 Relatively Safe Pharma Stocks You Can Buy Right NowThe Motley Fool
Sep-21-21 12:07PM AbbVie (ABBV) Files for Skyrizi in Crohn's Disease With FDAZacks Investment Research
10:32AM Biogen's (BIIB) Lucentis BioSimilar Byooviz Gets FDA ApprovalZacks Investment Research
Sep-19-21 11:01AM Is AbbVie a Bad News Buy?The Motley Fool
Sep-18-21 05:57AM AbbVie's Pain Is Sanofi's and Regeneron's GainThe Motley Fool
Sep-17-21 01:17AM Why BeiGene's Shares Jumped on FridayThe Motley Fool
07:40AM Pharma Stock Roundup: ABBV's Deal With RGNX, LLY COVID Drug's Government Order WinZacks Investment Research
Sep-16-21 09:05AM 2 Embarrassingly Cheap Dividend Stocks to BuyThe Motley Fool
Sep-15-21 11:29AM ObsEva (OBSV) Files NDA for Linzagolix to Treat Uterine FibroidsZacks Investment Research
11:00AM Is AbbVie's 4.9% Dividend Yield Safe?The Motley Fool
Sep-14-21 10:55AM REGENXBIO (RGNX) Stock Up on Collaboration Deal With AbbVieZacks Investment Research
10:51AM DiaMedica (DMAC) Initiates Pivotal Ischemic Stroke StudyZacks Investment Research
Sep-14-21 10:45AM AbbVie (ABBV) to Co-Develop Regenxbio Eye Disease Gene TherapyZacks Investment Research
10:24AM 5 Gene Therapy Stocks Back in Focus on AbbVie/Regenxbio DealZacks Investment Research
Sep-13-21 02:40AM Why Regenxbio Stock Is Way Up TodayThe Motley Fool
08:25AM AbbVie Selloff Is A Buying OpportunityInvesting.com
Sep-11-21 07:05AM These Promising Clinical Results Could Be Huge for Amgen InvestorsThe Motley Fool
Sep-10-21 09:55AM 3 Stocks to Watch in SeptemberThe Motley Fool
Sep-09-21 03:35AM Why Shares of Johnson & Johnson Are Down 2% TodayThe Motley Fool
01:55AM Is Berkshire Hathaway Trading in its Stock Portfolio?Zacks Investment Research
Sep-09-21 11:30AM Could This Label Expansion Be a Blockbuster for AbbVie's Shareholders?The Motley Fool
Sep-08-21 11:45AM Why AbbVie (ABBV) is a Top Dividend Stock for Your PortfolioZacks Investment Research
07:45AM Concerned About Volatility In AbbVie Stock? Try A 'Poor Person's Covered Call'Investing.com
Sep-07-21 01:31AM Top Analyst Reports for Facebook, AbbVie & 3MZacks Investment Research
Sep-06-21 11:28AM Impel (IMPL) Gets FDA Nod for Trudhesa in Migraine TreatmentZacks Investment Research
Sep-04-21 04:04AM The Latest Barron's Picks And Pans Include General Electric, Netflix, Reddit And MoreBenzinga
09:30AM How To Retire With A Million In 10 Years And Live Off DividendsSeeking Alpha
Sep-03-21 10:06AM Pharma Stock Roundup: New Warning Order by FDA for JAK Drugs, & Pipeline UpdatesZacks Investment Research
Sep-02-21 11:34AM AbbVie (ABBV) Stock Down as FDA Issues New Warning for RinvoqZacks Investment Research
10:11AM BeiGene (BGNE) Gets FDA Nod for Brukinsa Label ExpansionZacks Investment Research
Sep-02-21 09:17AM FDA Orders Warnings on Pfizer, Lilly, AbbVie JAK Drug LabelsZacks Investment Research
08:34AM FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To KnowBenzinga
Sep-02-21 08:19AM The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses ForalumabBenzinga
06:02AM 3 Biotech Stocks That Are Too Cheap to IgnoreThe Motley Fool
Sep-01-21 03:55AM Why AbbVie Is Down More Than 7% TodayThe Motley Fool
06:16AM 3 Investing Strategies to Grow Your Money Like MagicThe Motley Fool
Sep-01-21 05:52AM 3 Top Warren Buffett Stocks to Buy in SeptemberThe Motley Fool
Aug-31-21 02:00AM Attention Biotech Investors: Mark Your Calendar For September PDUFA DatesBenzinga
10:00AM If You're Retired, Consider Buying These 2 StocksThe Motley Fool
Aug-30-21 10:51AM Sanofi (SNY)/Regeneron's Dupixent Meets Eczema Study GoalZacks Investment Research
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune diseases; IMBRUVICA, an oral therapy for treating chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, to treat adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid for hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a treatment for relapsing forms of multiple sclerosis. It serves wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaboration with Alector, Inc.; C2N Diagnostics; Voyager Therapeutics, Inc.; Janssen Biotech, Inc.; International Myeloma Foundation; Calibr and Scripps Research; The Institute for Research in Immunology and Cancer – Commercialization of Research; the Université de Montréal; Tolero Pharmaceuticals, Inc.; Galapagos; Mission Therapeutics Ltd; and Bristol-Myers Squibb Company. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Cap:    |  Volume (24h):